Perspective Therapeutics, Inc. (CATX)
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
$3.13+0.32%
Close 2026-09-04 · 1-day change
AMEXHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · CATX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | FY 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | FY 2014 | FY 2013 | FY 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | — | — | — | 0.0 | 10.8 | 10.1 | 9.7 | 7.3 | 5.9 | 4.8 | 4.8 | 4.6 | 4.2 | 4.5 | 5.1 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 5.9 | — | — | — | — | — | — |
| Cost of Revenues | — | — | — | — | — | 6.2 | 4.9 | 4.6 | 4.3 | 4.1 | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | 0.0 | 0.0 | 5.1 | 5.1 | 3.0 | 1.8 | 0.8 | 0.1 | 0.2 | (0.2) | 0.2 | 0.7 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 85.8 | 84.2 | 84.2 | 41.6 | 0.9 | 0.9 | 1.4 | 1.1 | 1.5 | 1.7 | 1.0 | 0.5 | 0.6 | 0.7 | 0.6 | 0.8 |
| Operating Income | (115.1) | (113.6) | (113.6) | (90.9) | (8.7) | (6.4) | (3.4) | (3.5) | (5.3) | (6.7) | (6.3) | (5.1) | (4.3) | (4.6) | (4.1) | (3.6) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | 0.0 | 0.0 | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — |
| Interest & Investment Income | 9.1 | 8.1 | 8.1 | 10.5 | 0.6 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.2 | 0.3 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | (0.6) | (0.1) | — | — | — | (0.0) | (0.1) | (0.2) | (0.3) | — | — | — |
| Other Non-Operating Income / Expenses | 8.7 | 9.1 | 9.1 | 10.5 | 0.6 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | 0.4 | 0.7 | (1.4) | 0.2 | 0.1 |
| EBT, Incl. Unusual Items | — | (104.4) | (104.4) | (80.4) | (8.1) | (6.3) | — | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | (0.8) | (0.8) | (2.1) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (106.0) | (103.1) | (103.1) | (79.3) | (10.8) | (7.3) | (3.4) | (3.4) | (5.1) | (6.7) | (6.2) | (4.7) | (3.7) | (6.0) | (3.9) | (3.5) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.88) | (1.40) | (1.40) | (1.23) | (0.08) | (0.05) | (0.03) | (0.05) | — | — | — | — | — | — | — | — |
| Diluted EPS | (0.88) | (1.40) | (1.40) | (1.23) | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 120.7 | 73.8 | 73.8 | 64.4 | 142.1 | 142.0 | 103.8 | 67.6 | — | — | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 120.7 | 73.8 | 73.8 | 64.4 | — | — | — | — | — | — | — | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (110.3) | (110.3) | (88.6) | — | — | — | — | — | — | (6.2) | (4.6) | (3.8) | (3.9) | (3.3) | (2.8) |
| EBIT | (115.1) | (113.6) | (113.6) | (90.9) | (8.7) | (6.4) | (3.4) | (3.5) | (5.3) | (6.7) | (6.3) | (5.1) | (4.3) | (4.6) | (4.1) | (3.6) |
| Effective Tax Rate | — | 0.8% | — | — | 0.0% | 0.0% | — | — | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.